Innovating Works

VitaDisc

Financiado
A novel non-invasive therapy based on injectable viscous gel for restoring the n...
A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain Over 400 million people globally suffer from back pain. Disc degeneration disease is the prevalent cause of back pain and it is responsible for high social and economic costs. Current treatments are only symptomatic (physiotherapy... ver más
30/09/2025
NC BIOMATRIX BV
5M€
Presupuesto del proyecto: 5M€
ver más
Líder del proyecto
NC BIOMATRIX BV No se ha especificado una descripción o un objeto social para esta compañía.
Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-06-23
HORIZON-EIC-2022-ACCELERATOROPEN-01: EIC Accelerator Open Scope:The EIC Accelerator supports companies (principally SMEs, including start-ups) to scale up hig...
Cerrada hace 1 año
0% 48% 100%